NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1467541508 M. D.
Verify on CMS → Marta Recasens, M. D.
Ophthalmology Physician in Glendale, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 310 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
33%
generic claims · 67% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · Exceptional
Industry payments
$388.61
8 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Marta Recasens, M. D. reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 2,208 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 2K
- Part D claims, 2023
- 33%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Marta Recasens, M. D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Marta Recasens, M. D. sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Marta Recasens, M. D. writes more Part D claims than 76% of them and scores higher on MIPS quality than 85% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Marta Recasens, M. D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Marta Recasens, M. D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Marta Recasens, M. D.?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
2,208 55% vs specialty avg
MIPS final score
100/100 16.9 pts vs avg
Specialty distribution in California
How Ophthalmology Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Marta Recasens, M. D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 100/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Marta Recasens, M. D. appears in the CMS NPPES registry as an Ophthalmology Physician provider holding M. D. credentials at 1111 N BRAND BLVD STE 320, Glendale, CA, 91202, with a listed phone of (818) 552-2140. NPI 1467541508 was issued on 10/12/2006.
Medicare Part D records for calendar year 2023 show 2,208 prescription claims written by this provider, covering 310 Medicare beneficiaries and totaling roughly $473K in drug spend, split 67% brand-name and 33% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1467541508 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M. D. |
| Gender | Female |
| NPI Issued | 10/12/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Avg: 83.1
100
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Marta Recasens, M. D.. Source: openpaymentsdata.cms.gov.
Total received
$389
Largest payer
Astellas Pharma US Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Marta Recasens, M. D.. To verify Marta Recasens, M. D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Marta Recasens, M. D. - brand share 67.0%
Ophthalmology Physician average
67% brand-name claims vs 33% generic, on 2,208 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,208
Total Claims
$473K
Total Drug Cost
310
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,806
- Total Day Supply
- 78,176
- Brand vs Generic
- 67% brand / 33% generic
- Brand Drug Cost
- $439K
- Generic Drug Cost
- $34K
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 78.7 years
- Avg HCC Risk Score
- 1.97
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 13, 65-74: 91, 75-84: 113, 85+: 93
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Marta Recasens, M. D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
224 claims
- Prolensa
Prolensa
208 claims
- Lumigan
Lumigan
159 claims
- Alphagan P
Alphagan P
146 claims
- Ketorolac Trometha…
Ketorolac Tromethamine
142 claims
- Dorzolamide Hcl
Dorzolamide Hcl
113 claims
- Fluorometholone
Fluorometholone
111 claims
- Brimonidine Tartrate
Brimonidine Tartrate
110 claims
| Drug | Claims |
|---|---|
| Latanoprost | 224 |
| Prolensa Bromfenac Sodium | 208 |
| Lumigan Bimatoprost | 159 |
| Alphagan P Brimonidine Tartrate | 146 |
| Ketorolac Tromethamine | 142 |
| Dorzolamide Hcl | 113 |
| Fluorometholone | 111 |
| Brimonidine Tartrate | 110 |
| Combigan Brimonidine Tartrate/Timolol | 107 |
| Restasis Cyclosporine | 107 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Marta Recasens, M. D. fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Marta Recasens, M. D.'s 2,208 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Recasens.
Dr. Sam Abbassi
MD, MS
West Hills, CA
Dr. Richard Abbott
M.D.
San Francisco, CA
Dr. Nizar Abdelfattah
MD
Pasadena, CA
Dr. Parastou Abedi
MD
Aliso Viejo, CA
Dr. Shahla Abedi
MD
Aliso Viejo, CA
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Marta Recasens, M. D.'s specialty? ▼
Marta Recasens, M. D. specializes in Ophthalmology Physician and practices in Glendale, California. Credentials: M. D..
How much does Marta Recasens, M. D. prescribe under Medicare Part D? ▼
In 2023, Marta Recasens, M. D. wrote 2,208 Medicare Part D claims totaling $473K in drug costs for 310 beneficiaries.
What is Marta Recasens, M. D.'s Medicare quality score? ▼
Marta Recasens, M. D. has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Marta Recasens, M. D. located? ▼
Marta Recasens, M. D. is located at 1111 N BRAND BLVD STE 320, Glendale, CA, 91202. Phone: (818) 552-2140.
What is Marta Recasens, M. D.'s NPI number? ▼
Marta Recasens, M. D.'s National Provider Identifier (NPI) is 1467541508, issued on 10/12/2006.
Does Marta Recasens, M. D. prescribe more brand-name or generic drugs? ▼
Marta Recasens, M. D.'s prescribing is 67% brand-name and 33% generic drugs by claim count, with $439K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Marta Recasens, M. D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Marta Recasens, M. D.'s most frequently prescribed drugs include Latanoprost, Prolensa, Lumigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Marta Recasens, M. D. accept Medicare? ▼
Marta Recasens, M. D. appears in CMS Medicare data with 2,208 Part D claims and 310 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Marta Recasens, M. D.'s credentials? ▼
Marta Recasens, M. D.'s NPI is 1467541508 with credentials M. D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.